PET/CT Based Radiomics for Lung Cancer (PERL)
NCT03517306 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2019-04-04
Summary
The investigators investigate the utility of FDG PET/CT based radiomics in lung cancer, including diagnosis and prognosis.
Conditions
Interventions
- OTHER
-
No Interventions
No Interventions
Sponsors & Collaborators
-
Beijing Chao Yang Hospital
collaborator OTHER -
General Hospital of Ningxia Medical University
collaborator OTHER -
Soochow University
collaborator OTHER -
First Affiliated Hospital of Wenzhou Medical University
collaborator OTHER -
Second Affiliated Hospital of Wenzhou Medical University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-05-01
- Primary Completion
- 2019-05-31
- Completion
- 2019-09-28
Countries
- China
Study Locations
More Related Trials
-
Comparison of 68Ga-FAPI-46 PET and 18F-FDG PET in Lung Cancer
NCT05617742 ·Status: COMPLETED ·Phase: NA
-
PD-L1 PET Imaging in Patients With the Immunotherapy for Non-small Cell Lung Cancer
NCT05533086 ·Status: UNKNOWN
-
Clinical Application of MR-PET in Non-small Cell Lung Cancer: Diagnosis, Treatment Outcome, and Prognosis Prediction
NCT03053804 ·Status: UNKNOWN ·Phase: NA
-
Radiomics for prEdiction of lunG cAncer biologY
NCT05819905 ·Status: UNKNOWN
-
Feasibility Study of Radiation Therapy With Wide Detector 4DCT Scanning for Primary or Metastatic Lung Cancer
NCT06233396 ·Status: COMPLETED
-
Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
NCT04276025 ·Status: COMPLETED
-
Benefit of Spectral Information in Patients Suspected for Lung Cancer
NCT06440616 ·Status: RECRUITING ·Phase: NA
-
Precision Diagnosis and Therapy for Early Stage Lung Cancer
NCT02936804 ·Status: UNKNOWN ·Phase: NA
-
Surveillance With PET/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy
NCT03740126 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Deep Learning Signature for Predicting Occult Nodal Metastasis of Clinical N0 Lung Cancer
NCT05425134 ·Status: UNKNOWN
-
Efficacy and Safety of Prophylactic Cranial Irradiation Versus MRI Surveillance in Patients With Limited-stage Small Cell Lung Cancer Who Achieved Remission After First-line Chemoradiotherapy
NCT04829708 ·Status: RECRUITING ·Phase: PHASE3
-
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
NCT07316309 ·Status: COMPLETED
-
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
NCT02898441 ·Status: UNKNOWN ·Phase: NA
-
Using Imaging and Molecular Markers to Predict Tumor Response and Lung Toxicity in Lung Cancer
NCT00603057 ·Status: COMPLETED
-
Application of 4DCT-Based Pulmonary Ventilation Imaging in Lung Cancer Radiotherapy
NCT07312682 ·Status: ACTIVE_NOT_RECRUITING
-
Predicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
NCT07059923 ·Status: RECRUITING
-
Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
NCT05925751 ·Status: UNKNOWN
-
Multimodalitic Imaging in the N-stage of Lung Cancer
NCT05840094 ·Status: UNKNOWN ·Phase: NA
-
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217 ·Status: RECRUITING
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Ultralow-dose CT for Lung Cancer Screening
NCT04957030 ·Status: COMPLETED ·Phase: NA
-
PRedictive Value of Multiparametric Dynamic WB 18F-FDG-PET Imaging on a LAFOV System for FIRST-line Chemo-immunotherapy Efficacy in Advanced Non-small-cell Lung Cancer: PROFIL-1
NCT06738680 ·Status: NOT_YET_RECRUITING
-
The Regression Pattern of Primary Lesions in Lung Cancer After Definitive Radiotherapy
NCT06692972 ·Status: RECRUITING
-
Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy
NCT00745797 ·Status: TERMINATED ·Phase: PHASE3
-
Multiplex Analysis of Circulating Tumor DNA
NCT03301961 ·Status: UNKNOWN